The Journal of antimicrobial chemotherapy

Keyphrases

Publications

volume 79, number 8, 2024

Johan Maertens, Monica A Slavin, Martin Hoenigl, George R Thompson Iii, Malcolm Richardson, Cornelia Lass-Flörl
Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases-a debate. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Deborah A Theodore, Amrita D Henneman, Angela Loo, Ryan K Shields, Gregory Eschenauer, Magdalena E Sobieszczyk, Christine J Kubin
Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Marie Wijk, Kamunkhwala Gausi, Samantha Malatesta, Sarah E Weber, Richard Court, Bronwyn Myers, Tara Carney, Charles D H Parry, Charles R Horsburgh, Laura F White, Lubbe Wiesner, Robin M Warren, Caitlin Uren, Helen M McIlleron, Frank Kloprogge, Paolo Denti, Karen R Jacobson
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Anna Gamell, Eneritz Velasco-Arnaiz, Maria Goretti López-Ramos, María Ríos-Barnés, Sílvia Simó-Nebot, Victoria Fumadó, Antoni Noguera-Julián, Clàudia Fortuny
Off-label use of dalbavancin in children: a case series. The Journal of antimicrobial chemotherapy 79 (8) (2024)

volume 79, number 9, 2024

Alex Howard, Peter L Green, Anoop Velluva, Alessandro Gerada, David M Hughes, Charlotte R Brookfield, William Hope, Iain Buchan
Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Yasmeen Abouelhassan, Joseph L Kuti, David P Nicolau, Kamilia Abdelraouf
Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Daniele Armenia, Vincenzo Spagnuolo, Maria C Bellocchi, Laura Galli, Leonardo Duca, Greta Marchegiani, Tommaso Clemente, Luca Carioti, Riccardo Lolatto, Leonardo Calza, Benedetto M Celesia, Antonio Cascio, Daniela Francisci, Annalisa Saracino, Carlo Torti, Maurizio Zazzi, Antonella Castagna, Maria-Mercedes Santoro, null null
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Alexandra David, Daniel Golparian, Susanne Jacobsson, Caleb Stratton, Pham Thi Lan, Ken Shimuta, Pam Sonnenberg, Nigel Field, Makoto Ohnishi, Christopher Davies, Magnus Unemo
In silico gepotidacin target mining among 33 213 global Neisseria gonorrhoeae genomes from 1928 to 2023 combined with gepotidacin MIC testing of 22 gonococcal isolates with different GyrA and ParC substitutions. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Nadia Jaidane, Océane Vanparis, Wejdene Mansour, Hervé Volland, Saoussen Oueslati, Thierry Naas
Evaluation of a novel lateral flow immunochromatographic assay for the rapid detection of KPC, NDM, IMP, VIM and OXA-48 carbapenemases in Gram-negatives. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Daniel Kiiza, Danial Rostami-Hochaghan, Yussif Alhassan, Kay Seden, Helen Reynolds, Julian P Kaboggoza, Miriam Taegtmeyer, Tao Chen, Elizabeth Challenger, Thokozile Malaba, Duolao Wang, Laura Else, Faye Hern, Jo Sharp, Megan Neary, Sujan Dilly Penchala, Catriona Waitt, Catherine Orrell, Angela Colbers, Landon Myer, Andrew Owen, Steve Rannard, Saye H Khoo, Mohammed Lamorde
Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Federico Barone, Andrea Giacomelli, Giacomo Casalini, Mario Corbellino, Alessia Lai, Andrea Gori, Spinello Antinori
Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Alexis Maillard, Léo Froelicher Bournaud, Jean Pastre, Benjamin Planquette, Perrine Parize, Fanny Lanternier, Camille Rasmussen, Camille Chenevier-Gobeaux, Cherifa Cheurfa, Sihem Benaboud, Caroline Charlier, Etienne Canoui
Penetration of isavuconazole into the epithelial lining fluid of patients with pulmonary fungal infections. Comment on: 'Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions'. The Journal of antimicrobial chemotherapy 79 (9) (2024)
C Palos, C Ierano, M J D Santos, I Leitão, P Nogueira, Rodney James, J A Paiva, K Thursky, P Sousa
Cultivating global antimicrobial stewardship: linguistic and cultural validation of the Australian National Antimicrobial Prescribing Survey appropriateness assessment definitions for Portugal. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Matteo Bassetti, Antonio Cascio, Francesco Giuseppe De Rosa, Marianna Meschiari, Roberto Parrella, Nicola Petrosillo, Alessandro Armuzzi, Flavio Caprioli, Francesco Dentali, Marcello Pani, Alberto Pilotto, Umberto Restelli, Maurizio Sanguinetti
Management of Clostridioides difficile infection: an Italian Delphi consensus. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Aylin Dizi Işik, Gülşen Akkoç, Zeynep Ergenc, Seyhan Yilmaz, Sevgi Aslan Tuncay, Burcu Parlak, Pınar Canizci Erdemli, Didem Buyuktas Aytac, Meryem Cagla Abaci Capar, Sevliya Öcal Demir, Eda Kepenekli Kadayifci
The use of fosfomycin in infections caused by multidrug-resistant pathogens, especially pneumonia in children: a five-year retrospective single-centre experience. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Lavinia Fabeni, Daniele Armenia, Isabella Abbate, Roberta Gagliardini, Valentina Mazzotta, Ada Bertoli, William Gennari, Federica Forbici, Giulia Berno, Lorenzo Piermatteo, Vanni Borghi, Carmela Pinnetti, Alessandra Vergori, Annalisa Mondi, Giustino Parruti, Fiorella Di Sora, Marco Iannetta, Miriam Lichtner, Alessandra Latini, Cristina Mussini, Loredana Sarmati, Carlo Federico Perno, Enrico Girardi, Andrea Antinori, Francesca Ceccherini-Silberstein, Fabrizio Maggi, Maria Mercedes Santoro, null null
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Yasmeen Abouelhassan, David P Nicolau, Kamilia Abdelraouf
Defining optimal sulbactam regimens for treatment of Acinetobacter baumannii pneumonia and impact of blaOXA-23 on efficacy. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Emmanuelle Gras, Tommaso Francesco Aiello, Mariana Chumbita, Antonio Gallardo-Pizarro, Patricia Monzó-Gallo, Christian Teijón-Lumbreras, Maria Suárez-Lledó, Laura Magnano, Montse Tuset, Maria Ángeles Marcos, Alex Soriano, Carolina García-Vidal
Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Gert-Jan Wijnant, Perrin Ngougni Pokem, Marie Coessens, Eleonora Cottone, Julian Ermtraud, Lieven Goeman, Steven Vervaeke, Sebastian G Wicha, Françoise Van Bambeke
Pharmacokinetics and pharmacological target attainment of standard temocillin dosing in non-critically ill patients with complicated urinary tract infections. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Caragh Miller, Pierre Giguère, Michaeline McGuinty, Jonathan Benjamin Angel
Breakthrough HIV viraemia on bictegravir/emtricitabine/tenofovir alafenamide in the third trimester of pregnancy. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Qiucheng Shi, Zhi Ruan, Ping Zhang, Huangdu Hu, Xinhong Han, Zhengan Wang, Tao Lou, Jingjing Quan, Wei Lan, Rui Weng, Dongdong Zhao, Xiaoxing Du, Yunsong Yu, Yan Jiang
Epidemiology of carbapenem-resistant Klebsiella pneumoniae in China and the evolving trends of predominant clone ST11: a multicentre, genome-based study. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Fátima Aguilar-Del-Castillo, Miriam Álvarez-Aguilera, José Tinoco-González, Iván Vaca, Laura Herrera-Hidalgo, María Paniagua, José Miguel Cisneros, Francisco Javier Padillo-Ruiz, Rosa M Jiménez-Rodríguez
Influence of the COVID-19 pandemic on the defined daily dose of antimicrobials in patients requiring elective and emergency surgical procedures. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Leah M C Mcgee, Alemao G Carpinteyro Sanchez, Marina Perieteanu, Kaveh Eskandari, Yan Bian, Logan Mackie, Louise Young, Rebecca Beveridge, Colin J Suckling, Craig W Roberts, Fraser J Scott
Strathclyde minor groove binders (S-MGBs) with activity against Acanthamoeba castellanii. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Gabriele Bianco, Matteo Boattini, Sara Comini, Alessandro Bondi, Antonio Curtoni, Giorgia Piccinini, Tiziana Musso, Francesco Broccolo, Rossana Cavallo, Patrice Nordmann, Cristina Costa
Detection of volatile organic compounds as new paradigm to accelerate antimicrobial susceptibility testing: performance evaluation of VITEK® REVEAL™. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Jiyeon Bae, Jae Hyeon Park, Minkyeong Lee, Hyeon Jae Jo, Chan Mi Lee, Chang Kyung Kang, Pyeong Gyun Choe, Pyoeng Gyun Choe, Nam Joong Kim, Inho Kim, Myoung-don Oh
Clinicomicrobiological risk factors for infective endocarditis in viridans group streptococci bacteraemia. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Aram F Swinkels, Bjorn J A Berendsen, Egil A J Fischer, Aldert L Zomer, Jaap A Wagenaar
Extended period of selection for antimicrobial resistance due to recirculation of persistent antimicrobials in broilers. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Zenaw T Wolie, Jason Alexander Roberts, Mark Gilchrist, Kate L McCarthy, Fekade Bruck Sime
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Thibaut Gelé, Hélène Gouget, Nastasia Dimant, Valérie Furlan, Jon Collins, Erin M B Scholz, Chris M Parry, Roger Le Grand, Olivier Lambotte, Delphine Desjardins, Aurélie Barrail-Tran
Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Jianxing Zhou, Baohua Xu, You Zheng, Huiping Huang, Zipeng Wei, Shengyang Chen, Wei Huang, Maobai Liu, Yifan Zhang, Xuemei Wu
Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Ainoa Ugarte, Lorena De La Mora, Elisa De Lazzari, Iván Chivite, Emma Fernández, Alexy Inciarte, Montserrat Laguno, Juan Ambrosioni, Estela Solbes, Leire Berrocal, Ana González-Cordón, María Martínez-Rebollar, Alberto Foncillas, Júlia Calvo, José Luis Blanco, Esteban Martinez, Josep Mallolas, Berta Torres
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Huali Chen, Xiaoqing Zhou, Weijun Dai
Identification of antimicrobial-susceptible Pseudomonas aeruginosa RpoA variant strains through positional conservation pattern. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Ran Jing, Qiao-Lian Yi, Chao Zhuo, Wei Kang, Qi-Wen Yang, Yun-Song Yu, Bo Zheng, Yun Li, Fu-Pin Hu, Yang Yang, Jie Lin, Ge Zhang, Jing-Jia Zhang, Tong Wang, Jin Li, Chu-Yue Zhuo, Xue Li, Yun-Fan Zhu, Ying-Chun Xu
Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii and Staphylococcus aureus. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Andrew Hill, Tamara Tovar Sanchez, Eric Delaporte, Simiso Mandisa Sokhela, Bryony Simmons, Charles Kouanfack, Kaitlyn Mccann, Jacob Levi, Cassandra Fairhead, Willem Daniel Francois Venter
Low CD4 counts predict excessive weight gains during first-line treatment for HIV. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Leonie Feuer, Stefanie Katharina Frenzer, Roswitha Merle, Rasmus Leistner, Wolfgang Bäumer, Astrid Bethe, Antina Lübke-Becker, Babette Klein, Alexander Bartel
Prevalence of MRSA in canine and feline clinical samples from one-third of veterinary practices in Germany from 2019-2021. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Ying Huang, Zhongpeng Cai, Luchao Lv, Chao Yue, Jian Hua Liu
Emergence of mcr-8.1 gene coexisting with blaNDM in Citrobacter werkmanii isolated from a chicken farm in China. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Mazzitelli Maria, Domenico Pontillo, Tommaso Clemente, Antonio Di Biagio, Giovanni Cenderello, Stefano Rusconi, Barbara Menzaghi, Chiara Fornabaio, Elisa Garlassi, Maurizio Zazzi, Antonella Castagna, Anna Maria Cattelan, null null
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Karl A Glen, Iain L Lamont
Penicillin-binding protein 3 sequence variations reduce susceptibility of Pseudomonas aeruginosa to β-lactams but inhibit cell division. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Enya Arconada Nuin, Tuba Vilken, Xavier Basil Britto, Joachim Doua, Brian Morrow, Jeroen Geurtsen, Oscar Go, Bart Spiessens, Michal Sarnecki, Jan Poolman, Marc Bonten, Miquel Ekkelenkamp, Christine Lammens, Herman Goossens, Youri Glupczynski, Sandra Van Puyvelde, null null
A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Hongyu Zhou, Niccolò Buetti, Salvador Pérez-Galera, Jose Bravo-Ferrer, Belén Gutiérrez Gutiérrez, María Paniagua-García, Jan Feifel, Julien Sauser, Tomi Kostyanev, Rafael Cantón, Lionel K Tan, Dimitris Basoulis, Vicente Pintado, Emmanuel Roilides, Gorana Dragovac, Julian Torre-Cisneros, Deana Mediç, Murat Akova, Herman Goossens, Marc Bonten, Stephan Harbarth, Jesús Rodríguez-Baño, Jean-François Timsit, null null
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Nikolaos Fatsis-Kavalopoulos, Dione L Sánchez-Hevia, Dan I Andersson
Beyond the FIC index: the extended information from fractional inhibitory concentrations (FICs). The Journal of antimicrobial chemotherapy 79 (9) (2024)
Chuan-Guo Guo, Fang Jiang, Yueyue Li, Yijun Chen, Jialin Wu, Shutian Zhang, Wai K Leung
Real-world efficacy of second-line therapies for Helicobacter pylori: a population-based study. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Irene Cadenas-Jiménez, Lucía Saiz-Escobedo, Anna Carrera-Salinas, Xenia Camprubí-Márquez, Sara Calvo-Silveria, Paula Camps-Massa, Dàmaris Berbel, Fe Tubau, Salud Santos, M Angeles Domínguez, Aida González-Díaz, Carmen Ardanuy, Sara Marti
Molecular characterization of macrolide resistance in Haemophilus influenzae and Haemophilus parainfluenzae strains (2018-21). The Journal of antimicrobial chemotherapy 79 (9) (2024)
Yonatan M Mesfin, Joseph Edgar Blais, Kelemu Tilahun Kibret, Teketo Kassaw Tegegne, Benjamin John Cowling, Peng Wu
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in non-hospitalized adults with COVID-19: systematic review and meta-analysis of observational studies. The Journal of antimicrobial chemotherapy 79 (9) (2024)

volume 79, number Supplement_1, 2024

Eric C Fitts, E Alexander Dent, Eileen M Burd
Validation of short culture method for rapid bacterial identification of blood cultures via matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The Journal of antimicrobial chemotherapy 79 (Supplement_1) (2024)
Corrie C Simons, Gerald A Capraro
Barriers to implementation of rapid identification and antimicrobial susceptibility testing technologies in the clinical microbiology laboratory: an American perspective. The Journal of antimicrobial chemotherapy 79 (Supplement_1) (2024)
Shawn H MacVane, Hari P Dwivedi
Evaluating the impact of rapid antimicrobial susceptibility testing for bloodstream infections: a review of actionability, antibiotic use and patient outcome metrics. The Journal of antimicrobial chemotherapy 79 (Supplement_1) (2024)
Monica A Slavin, Alan Johnson
JAC Supplement: 'faster ID and AST revolution: how to improve antibiotic use in the critically ill'. The Journal of antimicrobial chemotherapy 79 (Supplement_1) (2024)
Sophie S Arbefeville, Tristan T Timbrook, Cherilyn D Garner
Evolving strategies in microbe identification-a comprehensive review of biochemical, MALDI-TOF MS and molecular testing methods. The Journal of antimicrobial chemotherapy 79 (Supplement_1) (2024)
Jeremy Frens, Tyler Baumeister, Emily Sinclair, Dustin Zeigler, John Hurst, Brandon Hill, Sonya McElmeel, Stéphanie Le Page
Getting rapid diagnostic test data into the appropriate hands by leveraging pharmacy staff and a clinical surveillance platform: a case study from a US community hospital. The Journal of antimicrobial chemotherapy 79 (Supplement_1) (2024)
Ismail Yuceel-Timur, Elise Thierry, Delphine Chainier, Ibrahima Ndao, Maud Labrousse, Carole Grélaud, Yohann Bala, Olivier Barraud
Retrospective evaluation of rapid genotypic ID and phenotypic AST systems on positive blood culture turnaround time and simulated potential impacts on bloodstream infection management. The Journal of antimicrobial chemotherapy 79 (Supplement_1) (2024)